搜索临床试验以:SHR-1916
总计1950个结果
-
Shanghai Zhongshan HospitalJiangsu HengRui Medicine Co., Ltd.未知
-
University of ChicagoNational Institute on Aging (NIA); University of North Carolina, Chapel Hill尚未招聘
-
Clarity Pharmaceuticals Ltd完全的
-
University Hospital Inselspital, BerneUniversity of Bern; CSEM Centre Suisse d'Electronique et de Microtechnique SA - Recherche et...完全的
-
West German Center of Diabetes and Healthgbo Medizintechnik AG完全的
-
Sun Yat-sen UniversityChongqing University Cancer Hospital; Jiangxi Provincial Cancer Hospital; Shenzhen People's Hospital 和其他合作者招聘中
-
Stanford UniversityGE Healthcare招聘中
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University完全的
-
Peking University People's HospitalJiangsu HengRui Medicine Co., Ltd.完全的
-
Narendranath Epperla撤销复发性边缘区淋巴瘤 | 复发性滤泡性淋巴瘤 | 难治性滤泡性淋巴瘤 | 难治性边缘区淋巴瘤 | 难治性淋巴结边缘区淋巴瘤 | 复发性淋巴结边缘区淋巴瘤 | 复发性脾边缘区淋巴瘤 | 难治性脾边缘区淋巴瘤 | 难治性惰性非霍奇金淋巴瘤
-
Jon SnaedalKarolinska University Hospital; Ullevaal University Hospital; Zealand University Hospital; Rigshospitalet... 和其他合作者未知
-
Weill Medical College of Cornell UniversityNew York State Department of Health完全的
-
Hangzhou Cancer HospitalJiangsu HengRui Medicine Co., Ltd.未知
-
University of MichiganAgency for Healthcare Research and Quality (AHRQ)完全的
-
Jiangsu HengRui Medicine Co., Ltd.招聘中先前接受过曲妥珠单抗和紫杉烷治疗的 HER2 阳性、不可切除和/或转移性乳腺癌受试者中国
-
Seres Therapeutics, Inc.完全的
-
Icahn School of Medicine at Mount SinaiNYC Health + Hospitals完全的
-
Acerta Pharma BV主动,不招人套细胞淋巴瘤 (MCL)比利时, 法国, 英国, 美国, 意大利, 波兰, 荷兰, 澳大利亚, 捷克语, 西班牙
-
H. Lee Moffitt Cancer Center and Research InstituteJames and Esther King Biomedical Research Program完全的
-
University of MichiganEunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)终止
-
University of North Carolina, Chapel HillMayo Clinic; National Library of Medicine (NLM); University of Pittsburgh Medical Center; MedStar...招聘中